NEW YORK , Aug. 23, 2024 /PRNewswire/ — Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of DXC Technology Company (NYSE: DXC) between May 26, 2021 and May 16, […]
Tag: P. A.
MRNA Investors Have Opportunity to Lead Moderna, Inc. Securities Fraud Lawsuit
NEW YORK, Aug. 23, 2024 /PRNewswire/ — Why: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of securities of Moderna, Inc. (NASDAQ: MRNA) […]
DXCM Investors Have Opportunity to Lead DexCom, Inc. Securities Fraud Lawsuit
NEW YORK, Aug. 23, 2024 /PRNewswire/ — Rosen Law Firm, a global investor rights law firm, announces that a shareholder filed a class action on behalf of all purchasers of securities of DexCom, Inc. (NASDAQ: […]
BOLT Investors Have Opportunity to lead Bolt Biotherapeutics, Inc. Securities Fraud Lawsuit
NEW YORK, Aug. 23, 2024 /PRNewswire/ — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Bolt Biotherapeutics, Inc. (NASDAQ: BOLT) between February 5, 2021 and May 14, 2024, both […]
CVS Investors Have Opportunity to Lead CVS Health Corporation Securities Fraud Lawsuit
NEW YORK, Aug. 23, 2024 /PRNewswire/ — Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of CVS Health Corporation (NYSE: CVS) between May 3, 2023 and April 30, 2024, both […]
